Aurinia Pharmaceuticals Inc (AUPH): Price and Financial Metrics

Aurinia Pharmaceuticals Inc (AUPH)

Today's Latest Price: $6.23 USD

0.14 (2.30%)

Updated Nov 21 8:00pm

Add AUPH to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

AUPH Stock Summary

  • The ratio of debt to operating expenses for Aurinia Pharmaceuticals Inc is higher than it is for about just 0.39% of US stocks.
  • With a price/sales ratio of 923.33, Aurinia Pharmaceuticals Inc has a higher such ratio than 99.65% of stocks in our set.
  • Over the past twelve months, AUPH has reported earnings growth of 229.78%, putting it ahead of 94.57% of US stocks in our set.
  • Stocks that are quantitatively similar to AUPH, based on their financial statements, market capitalization, and price volatility, are PSTI, RARX, RVNC, ARDX, and MRTX.
  • AUPH's SEC filings can be seen here. And to visit Aurinia Pharmaceuticals Inc's official web site, go to
AUPH Daily Price Range
AUPH 52-Week Price Range

AUPH Stock Price Chart More Charts

AUPH Price/Volume Stats

Current price $6.23
Prev. close $6.09
Day low $6.00
Day high $6.25
50-day MA $5.25
200-day MA $6.04
52-week high $7.85
52-week low $3.52
Volume 1,413,200
Avg. volume 820,068
Dividend yield N/A
Market Cap 587.40M

Aurinia Pharmaceuticals Inc (AUPH) Company Bio

Aurinia Pharmaceuticals Inc., a clinical stage pharmaceutic] The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. The company was founded in 1993 and is based in Victoria, Canada.

AUPH Latest News Stream

Event/Time News Detail
Loading, please wait...

AUPH Latest Social Stream

Loading social stream, please wait...

View Full AUPH Social Stream

AUPH Price Returns

1-mo 27.66%
3-mo 7.97%
6-mo -7.57%
1-year 18.89%
3-year 92.28%
5-year 81.10%
YTD -8.65%
2018 50.55%
2017 115.71%
2016 -14.98%
2015 -32.14%
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6368 seconds.